168 related articles for article (PubMed ID: 29887261)
21. Proposal of a new staging system for mass-forming intrahepatic cholangiocarcinoma: a multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery.
Uenishi T; Ariizumi S; Aoki T; Ebata T; Ohtsuka M; Tanaka E; Yoshida H; Imura S; Ueno M; Kokudo N; Nagino M; Hirano S; Kubo S; Unno M; Shimada M; Yamaue H; Yamamoto M; Miyazaki M; Takada T
J Hepatobiliary Pancreat Sci; 2014 Jul; 21(7):499-508. PubMed ID: 24519806
[TBL] [Abstract][Full Text] [Related]
22. Implications of CA19-9 elevation for survival, staging, and treatment sequencing in intrahepatic cholangiocarcinoma: A national cohort analysis.
Bergquist JR; Ivanics T; Storlie CB; Groeschl RT; Tee MC; Habermann EB; Smoot RL; Kendrick ML; Farnell MB; Roberts LR; Gores GJ; Nagorney DM; Truty MJ
J Surg Oncol; 2016 Sep; 114(4):475-82. PubMed ID: 27439662
[TBL] [Abstract][Full Text] [Related]
23. Correlation of staging systems to survival in patients with resected hilar cholangiocarcinoma.
Zaydfudim VM; Clark CJ; Kendrick ML; Que FG; Reid-Lombardo KM; Donohue JH; Farnell MB; Nagorney DM
Am J Surg; 2013 Aug; 206(2):159-65. PubMed ID: 23746658
[TBL] [Abstract][Full Text] [Related]
24. Prognostic predictability of the new American Joint Committee on Cancer 8th staging system for distal bile duct cancer: limited usefulness compared with the 7th staging system.
Kang JS; Lee S; Son D; Han Y; Lee KB; Kim JR; Kwon W; Kim SW; Jang JY
J Hepatobiliary Pancreat Sci; 2018 Feb; 25(2):124-130. PubMed ID: 29239127
[TBL] [Abstract][Full Text] [Related]
25. Preoperative Risk Score and Prediction of Long-Term Outcomes after Hepatectomy for Intrahepatic Cholangiocarcinoma.
Sasaki K; Margonis GA; Andreatos N; Bagante F; Weiss M; Barbon C; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Guglielmi A; Itaru E; Aucejo FN; Pawlik TM
J Am Coll Surg; 2018 Apr; 226(4):393-403. PubMed ID: 29274841
[TBL] [Abstract][Full Text] [Related]
26. A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experience.
Hyder O; Marques H; Pulitano C; Marsh JW; Alexandrescu S; Bauer TW; Gamblin TC; Sotiropoulos GC; Paul A; Barroso E; Clary BM; Aldrighetti L; Ferrone CR; Zhu AX; Popescu I; Gigot JF; Mentha G; Feng S; Pawlik TM
JAMA Surg; 2014 May; 149(5):432-8. PubMed ID: 24599477
[TBL] [Abstract][Full Text] [Related]
27. Carcinoembryonic antigen, α-fetoprotein, and Ki67 as biomarkers and prognostic factors in intrahepatic cholangiocarcinoma: A retrospective cohort study.
Qiang Z; Zhang W; Jin S; Dai K; He Y; Tao L; Yu H
Ann Hepatol; 2021; 20():100242. PubMed ID: 32841741
[TBL] [Abstract][Full Text] [Related]
28. Elevated perioperative serum CA 19-9 levels are independent predictors of poor survival in patients with resectable cholangiocarcinoma.
Kondo N; Murakami Y; Uemura K; Sudo T; Hashimoto Y; Sasaki H; Sueda T
J Surg Oncol; 2014 Sep; 110(4):422-9. PubMed ID: 24889968
[TBL] [Abstract][Full Text] [Related]
29. Clinical Diagnosis and Staging of Intrahepatic Cholangiocarcinoma.
Bartella I; Dufour JF
J Gastrointestin Liver Dis; 2015 Dec; 24(4):481-9. PubMed ID: 26697575
[TBL] [Abstract][Full Text] [Related]
30. Intrahepatic cholangiocarcinoma prognostic determination using pre-operative serum C-reactive protein levels.
Lin ZY; Liang ZX; Zhuang PL; Chen JW; Cao Y; Yan LX; Yun JP; Xie D; Cai MY
BMC Cancer; 2016 Oct; 16(1):792. PubMed ID: 27733196
[TBL] [Abstract][Full Text] [Related]
31. The impact of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio among patients with intrahepatic cholangiocarcinoma.
Buettner S; Spolverato G; Kimbrough CW; Alexandrescu S; Marques HP; Lamelas J; Aldrighetti L; Gamblin TC; Maithel SK; Pulitano C; Weiss M; Bauer TW; Shen F; Poultsides GA; Marsh JW; IJzermans JNM; Koerkamp BG; Pawlik TM
Surgery; 2018 Sep; 164(3):411-418. PubMed ID: 29903509
[TBL] [Abstract][Full Text] [Related]
32. Prognostic Impact of Preoperative Lymph Node Enlargement in Intrahepatic Cholangiocarcinoma: A Multi-Institutional Study by the Kyushu Study Group of Liver Surgery.
Adachi T; Eguchi S; Beppu T; Ueno S; Shiraishi M; Okuda K; Yamashita Y; Kondo K; Nanashima A; Ohta M; Takami Y; Noritomi T; Kitahara K; Fujioka H
Ann Surg Oncol; 2015 Jul; 22(7):2269-78. PubMed ID: 25582737
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the AJCC 8th Edition Staging System for Pathologically Versus Clinically Staged Intrahepatic Cholangiocarcinoma (iCCA): a Time to Revisit a Dogma? A Surveillance, Epidemiology, and End Results (SEER) Analysis.
Kamarajah SK
J Gastrointest Cancer; 2019 Sep; 50(3):392-399. PubMed ID: 29512000
[TBL] [Abstract][Full Text] [Related]
34. Novel staging system using carbohydrate antigen (CA) 19-9 in extra-hepatic cholangiocarcinoma and its implications on overall survival.
Tella SH; Kommalapati A; Yadav S; Bergquist JR; Goyal G; Durgin L; Borad M; Cleary SP; Truty MJ; Mahipal A
Eur J Surg Oncol; 2020 May; 46(5):789-795. PubMed ID: 31954549
[TBL] [Abstract][Full Text] [Related]
35. Preoperative criterion identifying a low-risk group for lymph node metastasis in intrahepatic cholangiocarcinoma.
Yoh T; Hatano E; Seo S; Terajima H; Uchida Y; Taura K; Yasuchika K; Uemoto S
J Hepatobiliary Pancreat Sci; 2018 Jun; 25(6):299-307. PubMed ID: 29656560
[TBL] [Abstract][Full Text] [Related]
36. Factors influencing the prognosis of patients with intrahepatic cholangiocarcinoma.
Liu ZH; Chen Z; Ma LL; Li XH; Wang LX
Acta Gastroenterol Belg; 2012 Jun; 75(2):215-8. PubMed ID: 22870785
[TBL] [Abstract][Full Text] [Related]
37. Liver resection for intrahepatic cholangiocarcinoma in AJCC‑stage Ⅳ: An evaluation of the survival benefit and prognostic accuracy of current AJCC staging system on N and M classification.
Yuan L; Luo X; Lu X; Huang B; Cai Q
Oncol Rep; 2016 Nov; 36(5):2663-2672. PubMed ID: 27666632
[TBL] [Abstract][Full Text] [Related]
38. Prognostic comparison of the 7th and 8th editions of the American Joint Committee on Cancer staging system for intrahepatic cholangiocarcinoma.
Kang SH; Hwang S; Lee YJ; Kim KH; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Lee SG
J Hepatobiliary Pancreat Sci; 2018 Apr; 25(4):240-248. PubMed ID: 29450978
[TBL] [Abstract][Full Text] [Related]
39. Measurement of serum carcinoembryonic antigen, carbohydrate antigen 19-9, cytokeratin-19 fragment and matrix metalloproteinase-7 for detecting cholangiocarcinoma: a preliminary case-control study.
Lumachi F; Lo Re G; Tozzoli R; D'Aurizio F; Facomer F; Chiara GB; Basso SM
Anticancer Res; 2014 Nov; 34(11):6663-7. PubMed ID: 25368272
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic Value of Serum Biomarkers for Intrahepatic Cholangiocarcinoma.
Li Y; Huang Y; Chen J
J Coll Physicians Surg Pak; 2019 Oct; 29(10):962-966. PubMed ID: 31564271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
